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Acute injuries to skeletal muscle occur frequently, partly because muscles comprise a major proportion of total body mass and because many are located superficially where they are prone to trauma and they serve mechanical functions that place them under damaging loads. Muscle injuries have increased worldwide over the last 20 years, partly because of increased numbers of blast injuries in armed conflicts and musculoskeletal trauma in road traf fic accidents, which alone account for tens of millions of injuries every year 1 . In addition, recovery from medical conditions involving secondary loss of muscle mass can be greatly slowed by limited rates of muscle regeneration and growth, leading to prolonged functional impairment even after patients return to daily activities 2 . These medi cal complications will continue to increase in cost and fre quency as the world population ages. Thus, identifying interventions to improve muscle growth or regeneration following injury or disuse has immediate clinical value.
Functionally important links between muscle regen eration and inflammation after acute injury or periods of disuse have been assumed for decades. However, the collaborative efforts of developmental biologists, cellu lar immunologists and muscle pathophysiologists have only recently provided mechanistic links between muscle inflammation and regeneration, and have revealed a surprising level of coordination between the processes. Importantly, details of how leukocytederived molecules exert epi genetic controls on muscle have been identified. Although myeloid cells have taken 'centre stage' in studies of leukocyte regulation of muscle regeneration, new find ings also show unexpected roles for lymphoid cells in modulating regeneration. Perhaps most gratifying, recent advances are leading to new strategies through which manipulating the inflammatory response to muscle injury can be used to improve regeneration, not only following muscle trauma but also in chronic muscle diseases.
Key events in myogenesis and regeneration
The regeneration of muscle relies on processes that mainly reuse programmes of gene expression that are necessary for the embryonic growth of muscle. Muscle regeneration begins with the activation of myogenic pre cursor cells (MPCs) -known as satellite cells -that reside on the surface of muscle fibres 3 
. Following muscle damage, satellite cells escape quiescence and proliferate; some daughter cells continue to differen tiate, whereas others return to quiescence to replenish the reserve population of satellite cells. Postmitotic MPCs derived from activated satellite cells then form multinucleated myotubes and proceed through a stage of regeneration that is dominated by terminal differ entiation and growth. Throughout this process, each stage is coupled to changes in the expression of myo genic transcription factors that are encoded by master regulatory genes 3 (FIG. 1) . Quiescent satellite cells express the pairedbox transcription factor PAX7 but do not express the basic helix-loop-helix (bHLH) transcrip tion factor myoblast determination protein 1 (MYOD; they are PAX7 + MYOD − ). Activated satellite cells are PAX7 + MYOD + , and daughter MPCs that are commit ted to undergo differentiation express the bHLH protein myogenin. On the basis of this progression of develop mental events and changes in the expression of tran scription factors, regeneration is broadly divided into an early stage of MPC activation and proliferation, and a later stage of terminal differentiation and growth.
Satellite cells and their progeny are essential for muscle regeneration. For example, depleting satellite cells abolishes the regeneration of injured muscles [4] [5] [6] . However, satellite cell presence alone is insufficient for muscle regeneration; the cells must have the capacity to proceed through the sequence of activation, proliferation and differentiation. When this sequence is disrupted by 
Satellite cells
A population of muscle stem cells that are committed to the myogenic lineage and normally reside in a quiescent state at the surface of fully differentiated muscle fibres. They can be activated by muscle injury, leading them to proliferate and then either return to quiescence, fuse with existing muscle fibres or continue to differentiate to form new muscle fibres.
Myotubes
During muscle development and regeneration, postmitotic, mononucleated muscle cells fuse with neighbouring postmitotic muscle cells to form long, cylindrical, multinucleated myotubes. Eventually myotubes can grow to include hundreds of muscle nuclei, and they then undergo terminal differentiation to become mature muscle fibres.
Regulation of muscle growth and regeneration by the immune system
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Abstract | Diseases of muscle that are caused by pathological interactions between muscle and the immune system are devastating, but rare. However, muscle injuries that involve trauma and regeneration are fairly common, and inflammation is a clear feature of the regenerative process. Investigations of the inflammatory response to muscle injury have now revealed that the apparently nonspecific inflammatory response to trauma is actually a complex and coordinated interaction between muscle and the immune system that determines the success or failure of tissue regeneration.
mutation of MYOD, regeneration is impaired (despite there being an increase in the number of satellite cells in muscle) 7 . Finally, activated satellite cells must have the capacity to restore the reserve population of satellite cells following injury to maintain the regenerative poten tial of muscle. This was shown by satellite cell specific deletion of NUMB, a protein that regulates asymmet ric cell cleavage in which one daughter cell returns to the undifferentiated reserve population, and the other daughter cell proceeds to differentiate. Ablation of NUMB in PAX7expressing cells reduced satellite cell numbers and impaired regeneration, showing the need to restore reserve populations of satellite cells for successful muscle regeneration 8 .
The muscle immune system
Leukocytes are a nonobtrusive, longoverlooked com ponent of healthy skeletal muscle. Although they appear scant in histological observations, there are 500 to 2,000 leukocytes per mm 3 of adult, rodent limb muscles [9] [10] [11] , which is equivalent to approximately 10 9 leukocytes per litre of muscle. This is a surprisingly high number consid ering that leukocyte concentrations in the blood are 10 11 leukocytes per litre for a typical adult human; total blood contains approximately 4 × 10 11 leukocytes, whereas total muscle contains 4 × 10 10 leukocytes. Although intra muscular leukocytes comprise various diverse cell types, including CD8 + cytotoxic T cells, regulatory T (T reg ) cells, neutrophils and eosinophils, each population constitutes a small proportion of the total leukocyte population in healthy muscle. The vast majority of intramuscular leuko cytes are monocytes or macrophages located pri marily in either the sheath of connective tissue that sur rounds entire muscles or near blood vessels 12, 13 . Similarly to satellite cells, resident macrophages reside in a quies cent state in healthy muscle 14 , but increased muscle use or trauma causes their rapid activation, which is necessary for normal muscle regeneration.
Myeloid cell regulation of muscle regeneration Muscle-myeloid cell interactions during the early, proliferative stage of muscle regeneration. Muscle damage caused by acute trauma, burns, freezing, toxins, exercise or some diseases initiates a stereotypical inflam matory response in which the number of intramuscu lar leukocytes can rapidly increase more than 100fold
. Within hours, neutrophils (that express LY6G and high levels of CD11b (also known as integrinαM)) invade damaged muscle and reach maximum num bers at approximately 12 to 24 hours post injury, after which they rapidly return to nearnormal numbers [15] [16] [17] . Resident macrophages (that express F4/80, LY6C and CD11b, but lack expression of CXCchemokine recep tor 1 (CXCR1)) promote this marked neutrophil influx by releasing the neutrophil chemo attractants CXC chemokine ligand 1 (CXCL1) and CCchemokine ligand 2 (CCL2) 13 . Several compelling investigations have established the importance of CCL2mediated sig nalling in driving both muscle inflammation and muscle regeneration following injury, providing early evidence that muscle regeneration and growth are strongly influ enced by inflammation. For example, genetic ablation of Ccl2 or its receptor CCchemokine receptor 2 (Ccr2) in mice reduced macrophage numbers in injured muscle, and this reduction was accompanied by slowed growth of nascent muscle fibres 9, [18] [19] [20] [21] . Although CCL2mediated events are mostly driven by myeloid cells, T cells have unexpected, important roles in initiating the cascade of events leading to muscle repair. Genetic deletion of Cd8a reduced CCL2 production by T cells and impaired the recruitment of macrophages into muscle follow ing injury caused by injection of snake cardiotoxin (CTX) 22 ; this led to defects in muscle regeneration that were similar to those caused by deletion of Ccl2 or Ccr2 (REFS 9, (18) (19) (20) . The most interesting implications of these findings are that resident CD8 + T cells are early respond ers to acute muscle injury and that signalling through the T cell receptor on CD8 + T cells has an important role in promoting the innate immune response in injured muscle, thereby affecting regeneration.
Early invasion of injured muscle by neutrophils is a generic and indispensable response to acute muscle damage. As in other injuries, the early arrival of neutro phils in injured muscle enables them to condition the inflammatory environment to influence the activation state of subsequent immune cell populations. Following the onset of neutrophil invasion, circulating mono cytes and macrophages extravasate and enter a muscle environment that is enriched with proinflammatory cytokines, including interferonγ (IFNγ) and tumour necrosis factor (TNF) [23] [24] [25] [26] . Together, these cytokines can activate macrophages to a proinflammatory pheno type, and these macrophages are named M1 macrophages to reflect their activation by proinflammatory T helper 1 (T H 1)type cytokines [27] [28] [29] . This distinguishes them from M2 macro phages, which are activated by T H 2type cytokines and are associated with the resolution of inflammation and with tissue repair. However, the M1 versus M2 macrophage phenotype dichotomy represents polarized extremes of a range of phenotypes that does
Box 1 | Satellite cells in health and disease
Satellite cells, which are sometimes referred to as muscle stem cells, are a population of committed myogenic cells that normally reside in fully differentiated muscle. In young, perinatal mice, which experience rapid muscle growth, satellite cell nuclei comprise approximately one-third of total muscle nuclei, but their proportion declines steadily to less than 10% in healthy adults 109, 110 . Satellite cells are activated by numerous stimuli, including mechanical stresses, oxidative stress, endocrine factors and inflammatory factors. Early studies of satellite cell activation in injured muscle showed that the injured muscle itself was the source of 'wound hormones' that were released to activate satellite cells 111 . Once activated, the satellite cells enter the cell cycle but soon encounter an important developmental watershed event at which point daughter cells either continue to differentiate or return to the quiescent pool of satellite cells to self-renew that population. In healthy, young muscle, self-renewal and differentiation are balanced, and the pool of satellite cells is maintained. However, in injury and ageing, the population of satellite cells and the regenerative capacity of muscle reduce 112 , which may be attributable to an age-related bias of daughter cells to proceed to differentiate rather than to return to quiescence. Undoubtedly, numerous age-related and pathology-related factors influence the symmetry of satellite cell divisions and developmental fate. However, recent findings have shown an increase in serum interleukin-6 (IL-6) levels in ageing animals 113 , suggesting a role for immunomodulation in determining the developmental fate of satellite cells.
mdx mice
Mutant mice that lack dystrophin, the deficient gene product in Duchenne muscular dystrophy (DMD), which is a progressive, lethal, muscle-wasting disease in humans. Both mdx dystrophy and DMD involve an early, acute onset of muscle damage and inflammation. However, subsequent DMD pathology is more severe than mdx pathology, in which there is an extensive period of remission following initial onset.
not reflect the true diversity or plasticity of macrophage populations 30 . Even in individual macrophages isolated from injured muscle, transcripts associated with both the M1 and M2 phenotypes can be expressed simultaneously, which provides these macrophages with functions that differ from either polarized phenotype 31 . Furthermore, at any time point following injury, the inflammatory infiltrate will consist of a mix of macrophage phenotypes and diverse states of activation, with some macrophages expressing M1associated activation markers and neigh bouring macrophages expressing M2associated activa tion markers 32 . Nevertheless, the M1-M2 nomenclature is used in this Review to indicate the predominant bias of macro phage populations towards a proinflammatory (M1) or proregenerative (M2) phenotype, while recog nizing the phenotypic complexity of macrophages that reside between the extremes.
The inflammatory response during the early stages of muscle regeneration is coupled temporally and spatially to the initial stages of myogenesis, when satellite cells are first activated and begin to proliferate and differentiate (FIG. 2) . However, exactly how the initial inflammatory response and early myogenesis are coregulated has only recently emerged. Among several candidate molecules, IFNγ stands out as potentially important for coordi nating the initial inflammatory response with the early stages of regeneration. Within the first 24 hours follow ing acute muscle injury by CTX injection, IFNγ expres sion levels in the injured tissue increase, coinciding with increased numbers of neutrophils, macrophages and activated satellite cells expressing MYOD 25 . Furthermore, blockade of IFNγ signalling in injured muscle reduces the expression in macrophages of transcripts that indi cate M1 activation (such as those encoding interferon regulatory factor 1 (IRF1) and inducible nitric oxide synthase (iNOS)) 25 . As IFNγmediated induction of IRF1 and iNOS expression occurs through a signal trans ducer and activator of transcription 1 (STAT1)mediated pathway 33, 34 , these findings indicate that STAT1 signalling may have a role in IFNγmediated activation of macro phages in regenerating muscles. IFNγ also regulates macrophage phenotype in muscle from dystrophic mice (mdx mice) during the period of acute muscle damage and the following regenerative stage. Ablation of IFNγ expression in mdx mice reduces iNOS protein levels in muscle macrophages, increases the expression in vivo of transcripts that indicate M2 activation of macrophages (such as those encoding interleukin4 (IL4), arginase 1 (ARG1), monoglyceride lipase 2 (MGL2) and FIZZ1 (also known as resistinlikeα)) and shifts macrophages to a CD206 + M2biased phenotype in vivo 35 . Despite . If the cells continue to differentiate and lose the capacity to self-renew, they permanently downregulate PAX7 expression and begin to express the transcription factor MYOG, which is required for further differentiation and survival 123, 124 . Those PAX7 37 , the investigators did not find significant differences in the expression of some M1associated or M2associated tran scripts between the groups at any time point post injury. They also did not see elevations in the levels of transcripts associ ated with IFNγmediated induction of STAT1 sig nalling in sorted macrophage samples. Although numer ous differences could underlie incongruous outcomes when assessing macrophage activation states in vivo versus ex vivo, a potential biological explanation may be that the earliest time point examined in the ex vivo investigation used macrophages isolated from muscle 24 hours post injury or later, without a baseline compar ison group 36 . At 24 hours post injury, IFNγ expression has already been increased 25 , and macrophages have already been activated to an M1biased phenotype. Although the investigators also showed no significant difference in the levels of expression of some M1associated transcripts in LY6C + and LY6C − macrophages collected 24 hours post injury, which could indicate no activation to an M1biased pheno type at this stage, they also detected no significant difference in the expression of LY6C between the LY6C + and LY6C − groups at that time. Within the postinjury debris and inflammatory lesions that are dominated by neutrophils and by macro phages biased towards the M1 phenotype, the earliest stages of regeneration begin, and they are influenced by IFNγ 25, 35 . IFNγ regulates gene expression in muscle cells through a pathway mediated by MHC class II transacti vator (CIITA) 38, 39 . These dual roles of IFNγ, whereby it functions both to activate macrophages and to directly regulate myogenic cells in the process of differentiation, is reflected in the extended period of time during which its expression is increased following muscle injury; although it is first markedly increased at day 1 post injury, expres sion continues to increase until day 5 (REF. 25 ). Similarly to the pathway through which IFNγ activates macrophages to the M1biased phenotype, IFNγ receptor binding on MPCs activates the Janus kinase (JAK)-STAT1 signal ling pathway, leading to the expression of target genes, including CIITA 40 (FIG. 3a) . In MPCs, IFNγmediated induction of CIITA expression is essential for inhib iting MPC differenti ation. Whereas IFNγ normally suppresses the expression of myogenin, an essential transcription factor for muscle terminal differentiation, myogenin suppression did not occur if CIITA expres sion was knocked down 38 . Thus, IFNγmediated mech anisms are well suited for coordinating the immune response to muscle injury with the early stage of muscle regeneration. Although phagocytic macrophages biased towards the M1 phenotype remove debris resulting from muscle injury 23, 41, 42 , they also express IFNγ 25 , which may reinforce the macrophage phenotype and retain MPCs in a proliferative, non differentiated state so that their populations can expand and support tissue repair.
Despite the apparently effective mechanisms through which IFNγ coordinates the early stages of inflamma tion with the early stages of regeneration, IFNγ signal ling through CIITA at later stages could have negative consequences (FIG. 3a) . For example, if MPCs under going terminal differentiation are stimulated with IFNγ, genes encoding proteins required for the function of fully dif ferentiated muscle are suppressed 39 . This gene silencing is attributable to CIITAmediated increases in the expres sion and activity of the histone methyltransferase EZH2. EZH2 is the catalytic subunit of the Polycomb group 2 (PCG2) complex that represses gene transcription by tri methylating lysine 27 on histone 3 (H3K27me3) at the Polycombresponse element (PRE) near the promoters of target genes. Increased levels of IFNγ and CIITA increase the recruitment of PCG2 to the promoter region of some musclespecific genes, and this was associated with silencing of those genes in the late stages of differ entiation but not in the early stages 38, 39 . Although it is unknown whether these epigenetic effects occur in vivo, the observation suggests that increased levels of IFNγ at early stages of regeneration benefit repair, but persistent increases in inflammatory cells expressing IFNγ at later stages could impair recovery.
Investigation of the links between the pro inflammatory cytokine TNF and the epigenetic control of muscle regeneration has also provided insights into the mechanisms that coordinate muscle regeneration and the early stages of the inflammatory response (FIG. 3b) . Neutrophils and macrophages express most or all of the TNF in muscle following an acute injury 23, 24 . Although TNFinduced activation of nuclear factorκB (NFκB) mediated signalling in myeloid cells can influence their
Box 2 | Models of acute muscle injury and repair
Acute muscle injuries offer an attractive system for exploring interactions between the immune system and tissue regeneration because the onset of tissue damage is well defined and the time courses of inflammation and regeneration are predictable. Across the range of damage models, the regenerative processes appear similar, at least on first approximation. Models include those in which muscles undergo a period of unloading following a return to normal weight-bearing; in these models damage is minor and causes necrosis of only a small percentage of muscle fibres 14, 52, 56 . Intense exercise can produce structural damage in a large proportion of fibres 114 , whereas muscle freezing 18, 66 , crushing or injection of snake toxins 9, 21, 22, 26, 37, 57, 62, 97, 115, 116 can cause a huge amount of damage that destroys nearly all fibres at the injury site. However, recent direct comparisons of the inflammatory response in different injury models have revealed differences. For example, muscle neutrophilia persists for several days in muscle damaged by injection of cardiotoxin (CTX), the most common muscle injury model, whereas muscle neutrophilia is much more rapidly resolved in muscle injured by injection of notexin (NTX) or barium chloride (BaCl 2 ) 117 , or in muscle injured by exercise or modified loading 14, 42, 52, 56 . Although differences in the magnitude of injury may contribute to the differences between models, inflammation resolves more quickly in CTX-injured muscles than in BaCl 2 -injured or NTX-injured muscles 117 , indicating qualitative differences between models in the inflammatory response to acute injury. Part of the explanation may lie in unexamined differences in the response of the immune system to the toxins themselves, which not only injure the muscle but might also affect inflammatory cells. For example, many snake venoms including CTX and NTX contain phospholipase A2 (PLA2), which not only lyses the muscle cell membrane but also stimulates neutrophils, acts as an anticoagulant, is haemolytic, causes mast cell degranulation and activates macrophages [118] [119] [120] [121] . Snake venoms can also interact with endogenous PLA2 in the injured muscle to produce the same perturbations to the inflammatory response to injury 122 . activation and their interactions with injured muscle, TNF can also act directly on muscle cells to affect muscle regen eration. Pioneering work established that loss of TNF signalling in acutely injured muscle abrogated signalling through p38 mitogenactivated protein kinase 3 days post injury, when MPCs transition from the proliferative to the early differentiation stages of myogenesis 43 . In addi tion, the expression of myogenin was eliminated and muscle regeneration was greatly impaired. Delving into the mechanism underlying this effect showed that p38α activation in injured muscle led to the phosphorylation of EZH2, causing its recruitment to PCG2 and an associated increase in trimethylation of H3K27 at the PRE of PAX7 (REF. 44 ). These observations, combined with the finding that blockade of EZH2 resulted in increased expression of PAX7, support the model that TNFinduced signalling through p38α represses PAX7 expression through EZH2 activity, thereby suppressing the proliferation and promot ing the differentiation of MPCs. However, there are addi tional layers of complexity that determine the outcome of changes in H3K27 methylation. For example, mice that have a satellite cellspecific deletion of Ezh2 (Ezh2 mKO mice) have fewer satellite cells in noninjured muscle compared with noninjured muscle from wildtype mice 45, 46 ; this is the opposite to what would be predicted to occur on the basis of blocking TNFinduced signalling in injured muscle 44 . Furthermore, Ezh2 mKO mice show reduced expansion of satellite cell populations in injured muscle 45 , despite the finding that decreased EZH2 activity caused by blocking TNF and p38α signalling in injured muscle increases MPC numbers 44 . Although there are several possible explanations for the different outcomes, part of the explanation may lie in the stage of myo genesis at which MPC genes are silenced. In Ezh2 mKO mice, EZH2mediated effects on gene expression are perturbed during satellite cell quiescence and activation, whereas increased activation of EZH2 by TNF in the inflamed muscle of wildtype mice occurs in MPCs that were pre viously activated and proliferating. Recent findings high light that the stage of muscle regeneration determines how EZH2 activity affects myogenesis 46 . Although ablation of Ezh2 in Ezh2 mKO mice produces severe defects in regenera tive muscle and impairs MPC proliferation, mice in which floxed EZH2 is deleted by Cre recombinase driven by the myogenin promoter show no regenerative or proliferative defects 46 . In this mouse line, Ezh2 deletion occurs only in the later stages of myogenesis.
The discovery that TNF also has epigenetic effects on muscle regeneration by targeting NOTCH1 adds to the complex picture of how proinflammatory cytokines regulate regeneration. NOTCH1 is a transmembrane receptor that is expressed in muscle and other cells, in which it has a central role in regulating development. NOTCH1mediated effects on myogenesis are mainly attributable to the inhibition of MYOD, myogenin and myocytespecific enhancer factor 2C (MEF2C) expres sion 47 , which leads to the increased proliferation and reduced differentiation of MPCs 48 . The finding that the exposure of muscle to TNF increases EZH2mediated H3K27 methylation at the NOTCH1 promoter 49 identi fied a mechanism through which TNF could influence myogenesis in a manner that reinforced TNFinduced silencing of PAX7. By decreasing the expression of a protein that reduces the activity of transcription fac tors neces sary for MPC differentiation, TNFinduced silencing of NOTCH1 could reduce satellite cell numbers.
Together, these findings show that the two cytokines that can activate macrophages to the M1biased pheno type in injured muscle, IFNγ and TNF, also have important roles in regulating the proliferation and dif ferentiation of MPCs. Many of the effects are caused by EZH2mediated silencing of myogenic regulatory Nature Reviews | Immunology Within hours of trauma, muscles experience rapid activation of resident myeloid cells, and invasion by neutrophils and by macrophages that are biased towards an M1 phenotype. During the first 24 hours, the immune response is characterized by high levels of expression of tumour necrosis factor (TNF), which promotes the initial inflammatory response, and CC-chemokine ligand 2 (CCL2), which drives the recruitment of both myeloid and lymphoid populations. However, elevated expression of interleukin-10 (IL-10) coincides with the attenuation of the initial inflammatory response and with the reduced proliferation of myogenic precursor cells (MPCs) as they begin to exit the cell cycle and differentiate, which corresponds to a change in the macrophage population from an M1-biased phenotype to an M2-biased phenotype. The shift towards a pro-regenerative environment is also coupled with an increase in regulatory T (T reg ) cell numbers in the regenerative tissue. The time courses are compiled from aggregate data from numerous publications (REFS 20, 24, 25, 37, 42, 54, 56, 125) . ECM, extracellular matrix; IGF1, insulin-like growth factor 1; iNOS, inducible nitric oxide synthase.
genes. The findings also show that epigenetic events regulating myogenesis differ in injured and non injured muscles. This view is further supported by analysis of the effects of a satellite cellspecific deletion of the histone lysinespecific demethylase 6A UTX on muscle regen eration 50 . UTX demethylates H3K27 and can thereby activate genes silenced by EZH2. The importance of this demethylation is established in MPCs in vitro, in which UTX is essential for activating myogenin expres sion, which is required for terminal differentiation 51 . However, satellite cellspecific deletion of UTX showed no histologically discernible effect on healthy muscle Nature Reviews | Immunology structure, although it caused severe defects in regen eration following injury 50 . Whether this distinction is attributable to differences in compensatory mechanisms for H2K27 demethylation that are available in healthy developing muscle but not in mature injured muscle, or whether it reflects another mechanism, is unknown.
Muscle-immune cell interactions during the transition to the terminal differentiation stage of muscle regeneration. Collectively, the net effects of increasing TNF induced and IFNγinduced signalling at the early stage of regeneration drives macrophages to an M1biased state of activation, and regulates proliferation and early differ entiation of MPCs. This complex but welltuned system permits the expansion of the population of MPCs, some of which return to the reserve population of satellite cells, whereas others differentiate and grow into fully differen tiated muscle fibres. Early histological observations that relied on macrophage phenotyping on the basis of the level of expression of CD68 and CD163 showed that the peak number of CD68 hi CD163
− phagocytic M1 macro phages that occurred 2 days post injury was replaced by a popula tion of nonphagocytic CD68 low CD163 + M2 macrophages that reached peak numbers approximately 4 to 7 days post injury, coinciding with the expression of genes that are markers of terminal differentiation 52 . This suggested that the transition from an initial immune response, domi nated by phagocytic M1biased macrophages, to a type 2 immune environment, dominated by M2biased macro phages, could be functionally coupled to the transition in stages of myogenesis.
Although numerous signalling systems interact to influence the coordinated transitions in the immune environment and the stages of myogenesis, modifica tions in cytokine production over the course of regener ation are particularly important. For example, marked increases in the expression of IL10 accompany the tran sition of macrophages from an M1 to an M2 pheno type in injured muscle and correspond to the transition of regeneration from the proliferative stage to the differ entiation and growth stage of myogenesis 42, 53, 54 (FIG. 4) .
IL10induced activation of macrophages drives them to become an M2biased subpopulation that functions in immunoregulation and extracellular matrix deposi tion, and is characterized by elevated expression of IL10 and transforming growth factorβ (TGFβ) 55 . As has now been clearly shown, the transition from an M1biased to an M2biased macrophage phenotype in injured muscle is necessary for normal regeneration. Depletion of F4/80 + macrophages at the time of the M1biased to M2biased macrophage phenotype switch in regenerat ing muscle significantly slowed muscle growth, repair and regeneration, and disrupted the normal expression patterns of transcription factors that regulate regen eration 56 . Similar reductions in the growth of muscle fibres in muscle damaged by CTX injections occurred if CD11b + inflammatory cell numbers were reduced at the stage of peak muscle regeneration 57 . However, the transition in pheno type did not occur in injured muscles in which IL10 expression was ablated, and the loss of the IL10mediated phenotype switch caused impairments of regeneration resembling those caused by deletion of F4/80 + or CD11b + cells 42 . Although IL10 directly deactivates the M1 pheno type by inhibiting the expression of proinflammatory cytokines, it also induces the macrophage transition from the M1biased to the M2biased phenotype through mechan isms that may influence muscle regeneration. The discovery of a mechanism through which IL10 mediates changes in macrophage phenotype came, unexpectedly, from studies of metabolic pathways. In particular, AMP activated protein kinase (AMPK) has regulatory roles in inflammation and metabolism whereby it switches off ATPconsuming pathways in cells when ATP levels are low 58 . As M1biased macrophages are more glycolytic and M2biased macrophages more oxidative 59 , AMPK levels differ according to the state of macro phage polarization. For example, antiinflammatory cytokines, such as IL10 and TGFβ, rapidly activate AMPK, whereas stimulation with proinflammatory stimuli deactivates AMPK 60 . Conversely, AMPK regulates M1 to M2 polarization. In the well-characterized signalling pathway through which IFNγ activates the M1 phenotype, the cytokine binds its receptor, leading to the recruitment of the tyrosine kinases Janus kinase 1 (JAK1) and JAK2, which in turn phosphorylate and activate signal transducer and activator of transcription 1 (STAT1) and IFN-regulatory factor 1 (IRF1) 126 . Nuclear targeting of dimerized, phosphorylated STAT1 enables it to bind γ-activated sequences (GASs) of target genes, leading to the activation of a range of genes that can promote the pro-inflammatory M1 phenotype. Simultaneously, IFNγ-activated signalling in muscle cells through the JAK-STAT1 pathway increases the expression of MHC class II transactivator (CIITA). During early stages of myogenesis, CIITA binds directly to myogenin (MYOG) and inactivates it, preventing MYOG-mediated induction of myogenic genes that are required for muscle differentiation and function (for example, TNNI2 (which encodes fast skeletal muscle troponin I2 and LMOD2 encoding leiomodin 2)). This helps to retain myogenic precursor cells (MPCs) in an undifferentiated, proliferative state. In later stages of differentiation, increased levels of CIITA lead to its recruitment of EZH2 to the Polycomb-response element (PRE) of muscle-specific genes, which leads to their silencing and prevents the expression of genes that are required to reach the fully mature muscle phenotype. b | Increased release of tumour necrosis factor (TNF) coordinates early myogenic events with the initial inflammatory response during early stages of muscle injury and repair. Although numerous cells, including those of muscle itself, can express TNF, inflammatory cells are the primary sources at early stages post injury 24 . TNF binding to its receptor (TNFR) on macrophages activates signalling through TNFR-associated factor 2 (TRAF2), leading to activation of the inhibitor of nuclear factor-κB kinase (IKK), and the subsequent phosphorylation of inhibitor of nuclear factor-κB (IκB) and activation of nuclear factor-κB (NF-κB). Activated NF-κB then translocates to the cell nucleus to bind to the NF-κB-response element (NRE) of target genes to activate their expression. Expression of those target genes is essential to maintain the initial inflammatory response. Alternatively, the binding of molecules containing damage-associated molecular patterns (DAMPs), especially high mobility group protein B1 (HMGB1) can also activate NF-κB 127 . HMGB1 binds to Toll-like receptor 4 (TLR4) on macrophages to activate NF-κB via myeloid differentiation primary response gene 88 (MYD88) and TRAF6. At the same time, TNF can bind its receptor on the MPC surface to activate mitogen-activated protein kinase (MAPK) kinase 3 (MKK3) or MKK6, leading to the activation of the MAPK p38α. Phosphorylation of EZH2 by p38α causes EZH2 recruitment to the Polycomb repressive complex 2 (PRC2), which leads to binding at the PRE of target genes. Activated EZH2 then trimethylates histone 3 lysine 27 (H3K27) at the target genes, leading to their repression. Two functionally important target genes in activated satellite cells are PAX7 and NOTCH1, and their silencing prepares the satellite cells to transition to the early stages of differentiation. CCL2, CC-chemokine ligand 2; CXCL9, CXC-chemokine ligand 9; IFNγR, IFNγ receptor; IL, interleukin; IL-6R, IL-6 receptor; IL-15R, IL-15 receptor; iNOS, inducible nitric oxide synthase; PCG2, Polycomb group 2; SOCS, suppressor of cytokine signalling.
◀
Knockdown of AMPK increased the expression of pro inflammatory cytokines, whereas overexpression of AMPK αsubunit 1 (AMPKα1) in macro phages reduced TNF but increased IL10 expression 61 . These regulatory functions of AMPK also affect macrophage phenotype in regenerating muscle, thereby influen cing macrophage dependent regeneration. Myeloid cellspecific deletion of AMPKα1 in mice experi encing a CTXinduced muscle injury led to increased muscle damage, and slowed repair and growth 37 . In addition, bone marrowderived macrophages (BMDMs) from AMPKα1mutant mice showed less induction of CD163, CD206 and TGFβ1 expression following stimulation with IL10 or IL4 than did wildtype BMDMs 37 . Collectively, these findings support a model in which IL10 promotes the M2biased phenotype, increasing AMPK activ ity, which drives the production of antiinflammatory cytokines that further support type 2 immunity.
Much of the recent investigation of myeloid cell derived signals that affect the early stages of muscle regeneration has focused on chemokines and cytokines. However, myeloid cells also provide growth factors that influence the course and success of muscle regeneration and that affect macrophage phenotype. Unexpectedly,
M1-biased macrophage
Nature Reviews | Immunology . This corresponds to the activation of satellite cells to enter the cell cycle and to proliferate. The release of cytokines and chemokines, especially CC-chemokine ligand 2 (CCL2) and CXC-chemokine ligand 1 (CXCL1), from neutrophils, resident macrophages and CD8 + T cells promotes further recruitment of immune cells to an inflammatory response driven by interferon-γ (IFNγ) and tumour necrosis factor (TNF). Elevations in those pro-inflammatory cytokines sustain the initial inflammatory response but also act directly on myogenic precursor cells (MPCs) through epigenetic mechanisms to regulate their expression of myogenic-regulatory genes that control MPC development. Macrophages biased towards the M1 phenotype also release insulin-like growth factor 1 (IGF1), which increases MPC proliferation and further expands the MPC population. M1 macrophage populations then undergo a shift to a population that is biased towards the M2 pro-regenerative phenotype. Several ligands have important roles in promoting this phenotypic shift, including fibrinogen 129 , amphiregulin (AREG) and interleukin-10 (IL-10) produced by regulatory T (T reg ) cells, and IL-10 and IGF1 produced by macrophages. In addition, phagocytosis of cellular debris also contributes to the macrophage phenotypic switch. AREG release by T reg cells increases the expression of myogenicregulatory factors that drive the later stages of muscle differentiation. This influence is further enhanced by the recruitment of T reg cells to regenerated muscle by IL-33 released by fibro-adipogenic progenitor (FAP) cells and possibly by macrophages. FAP cell proliferation and differentiation into cells with phagocytic or fibrogenic phenotypes are influenced by the release of transforming growth factor-β (TGFβ) from macrophages and by IL-4 released by eosinophils. Those macrophages that differentiate to become fibroblasts then contribute to the extracellular matrix production that supports muscle repair and the release of IGF1, which increases the growth of fully differentiated muscle.
Macrophage memory
Cells of the innate immune system, including macrophages, can show changes in their response to immune challenges according to the conditions under which they differentiated or were previously activated. This 'trained' immunity or memory reflects epigenetic changes that influence signalling or metabolic pathways.
insulin like growth factor 1 (IGF1) released by M1biased macrophages is a strong mitogen for MPCs in muscle, and myeloid cellspecific deletion of IGF1 slows muscle growth following injury 62 . Although muscle fibres themselves are rich sources of IGF1 (REF. 63 ) and IGF1 is a wellknown mitogen for MPCs 64, 65 , musclederived IGF1 may not be available following severe muscle damage. In this case, local delivery of IGF1 by macrophages precisely at injury sites may promote regeneration. However, myeloid cellderived IGF1 also influences muscle regeneration through an autocrine effect on macrophages themselves (FIG. 4) . Loss of IGF1 in myeloid cells disrupts the transi tion of macrophages from an M1biased to an M2biased phenotype in injured muscle 62 , which can contribute to slowed growth of injured muscle.
Other subtle factors coordinate changes in the innate immune environment with stages of myogenesis. For many years, those studying muscle regeneration noted that perturbations that slow phagocytic removal of apop totic cells and other debris were associated with delayed regeneration 17, 19, 57, 66, 67 . On the one hand, defective regen eration among large amounts of persistent debris was not surprising; the prolonged accumulation of debris could provide a physical obstacle to the regeneration. On the other hand, the phagocytic removal of debris also has more specific regulatory roles, in addition to creating space for repair. For example, macrophage phagocyto sis of apoptotic neutrophils suppressed the expression of TNF, and phagocytosis of necrotic or apoptotic neutrophils increased the expression of TGFβ, which indicates a shift towards an M2biased phenotype 68, 69 . Similarly, phagocytosis of necrotic MPCs isolated from muscles reduced TNF and increased TGFβ production by muscle derived macrophages 57 . Thus, signalling acti vated by phagocytosis can promote a shift in macrophage phenotype that supports muscle regeneration.
Once again, the phenotypic switch associated with macrophage phagocytosis is attributable, at least in part, to AMPKmediated signalling. Phagocytosis of apoptotic cells by macrophages increased AMPK activity 70 , and elevations in AMPK activity increased phago cytosis 70 and biased macrophages towards an M2 phenotype 61 . Similarly, phagocytosis of apoptotic MPCs by BMDMs caused an AMPKinfluenced shift towards an M2biased phenotype; unlike BMDMs from wildtype mice, BMDMs from AMPKα1mutant mice showed no induc tion of CD163, CD206 or TGFβ expression after phago cytosis of apoptotic MPCs 37 . These in vitro observations, combined with the finding that defects in the regenera tion of CTXinjured muscle in AMPKα1mutant mice were partially rescued by the transplantation of bone marrow derived cells from wildtype mice, show that regeneration is improved by AMPKmediated signalling that is initiated by phagocytosis in macrophages.
Although these findings show that immunoregula tory signals that are activated by macrophage apoptosis have considerable effects on muscle regeneration, obser vations in other systems indicate that phagocytosis of apoptotic bodies may have longerterm effects on the response of muscle to injury. Most interestingly, recent discoveries show that phagocytosis of apoptotic bodies in infected tissues can generate a form of immunological memory in macrophages that facilitates their ability to quickly recognize and respond to apoptotic cells and tis sue damage 71 . This suggests that sterile injuries in tissues, including muscle, that lead to phagocytosis of apoptotic cells by macrophages could also condition macrophage memory and influence the ability of macrophages to respond to subsequent injuries.
Muscle-immune cell interactions during the terminal differentiation and growth stage of muscle regeneration.
Beginning with the earliest observations that changes in macrophage polarization coincided with muscle regen eration, CD163 was identified as a specific marker of the macrophage phenotype that predominated during the terminal differentiation and growth stage of regenera tion 52 . Now, we know that CD163 also regulates macro phage phenotype and muscle regeneration. CD163 is a transmembrane glycoprotein that is constitutively expressed by macrophages 72 , although its expression is strongly influenced by cytokines. For example, TNF downregu lates CD163 expression 73 , whereas IL10 is a powerful inducer of CD163 expression [72] [73] [74] . CD163 facilitates tissue regeneration by binding haemo globinhaptoglobin complexes, which enables the complexes to be internalized and degraded 75, 76 . This is important in regeneration because haemolysis in injured tissue causes local, toxic elevations of haemoglobin that amplify dam age 77 . CD163 binding also increases the expression of IL10, which further promotes its antiinflammatory effects 78 . Presumably, immunoregulatory functions of membranebound CD163 improve muscle regenera tion because systemic ablation of CD163 exacerbated muscle damage caused by ischaemia, slowed muscle growth and delayed the normal myogenic programme required for regeneration 79 . However, injury also caused the release of the extra cellular domain of CD163 into the serum 79 , and this soluble CD163 inactivated the pro inflammatory cytokine TNFrelated weak inducer of apoptosis (TWEAK; also known as TNFSF12) 79, 80 . As soluble CD163 reverses the changes in NFκB activation induced by TWEAK in ischaemic muscle, and TWEAK directly activates NFκB and promotes MPC prolifera tion, part of the pro regenerative effect of CD163 may occur by preventing perturbations in myogenesis induced by TWEAK. However, this protective effect of CD163 must be placed in the context of apparently complex find ings concerning the role of TWEAK signalling in muscle regeneration. On the one hand, systemic ablation of the TWEAK receptor FGFinducible 14 (FN14; also known as TNFRSF12A) slowed the regeneration of CTXinjured muscle 81 , but, on the other hand, systemic deletion of TWEAK improved muscle growth following injury 82 .
Lymphoid cell regulation of muscle regeneration
Interest in immune cell regulation of muscle regeneration has focused on myeloid cells because of their vast pre ponderance in regenerating muscle. However, just as for myeloid cells, early histological observations showed that CD4 + and CD8 + lymphoid cells appeared in elevated num bers in injured and regenerating muscle 83 . However, those 56 . These effects of T reg cell depletion may be partly mediated by the disruption of their regulation of macrophage phenotype; T reg cell deple tion impaired the normal transition from the M1biased to the M2biased macrophage phenotype in the regener ating muscle. However, T reg cells can also have effects on regeneration 84 that may be influenced by T reg cellderived IL10 (REFS 10, 85) or amphiregulin 84 .
The most interesting story concerning the regulatory interactions between T reg cells and muscle may remain to be discovered. As T reg cells that reside in healthy muscle 11 have the ability to regulate the immune response and to directly influence muscle differentiation, they are ideally situated to act as monitors that coordinate immune cell interactions with muscle during regeneration. They may also provide muscle with a memory. Sequencing of T cell receptors (TCRs) from musclederived T reg cells showed identical paired complementaritydetermining region 3α (CDR3α) and CDR3β in multiple mice assayed after injury 84 . However, the conserved CDR3 sequences did not occur in splenic T reg cells or in conventional T cells from muscle. This introduces the possibility not only that there is a common antigen or antigens driving T reg cell activation in regenerating muscle, but also that there may be memory T reg cells that regulate the response to commonly encountered TCR ligands produced by muscle damage.
Immune cell interactions with FAP cells in muscle As presented above, inflammatory cells influence muscle regeneration through direct, instructive interactions that can affect gene expression in MPCs. However, they also promote regeneration through permissive interactions in which they influence the myogenic environment so that regeneration can proceed. A particularly important example of these permissive interactions is provided by the role of myeloid cells in influencing the function of a muscleresident population of mesenchymal cells that express plateletderived growth factor receptorα (PDGFRα); these cells are known as fibro-adipogenic progenitor cells (FAP cells) 86, 87 . Similarly to satellite cells and muscleresident macro phages, FAP cells in healthy muscle are quiescent but become rapidly activated following injury or intense exercise. Resembling the kinetics of macrophages and satellite cells, they reach peak numbers 3 days post injury, declining to noninjured control levels by day 14 (REF. 87 ).
Much of the time course of the expansion and decline of FAP cell populations following injury is determined by myeloid cells. For example, IL4 derived from eosino phils may increase FAP cell proliferation and bias them towards a phagocytic phenotype at early stages post injury 32 . FAP cells are then eliminated by apoptosis that is driven by TNF released from M1biased macrophages 31 . However, during their few days of profibrotic activity, they modulate the developmental programme of MPCs to influence the course of muscle regeneration 31, 88 . A particularly delicate interplay between macro phages and FAP cells regulates the production of the extracellular matrix scaffold that is necessary for muscle regeneration. FAP cells that are activated to the fibrogenic phenotype are regulated by M2biased macrophages that release TGFβ, which prevents TNFmediated induction of FAP cell apoptosis and leads to the expansion of the FAP cell population and their differentiation into a fibro genic phenotype 31 (FIG. 5) . As fibrogenic FAP cells are pri mary producers of connective tissue in injured muscle 89 , these macrophagemediated effects have a key role in determining the quantity and quality of connective tis sue production. In addition, TGFβmediated activation of dermal fibroblasts increases the expression of genes such as those encoding collagen type 1 and connective tissue growth factor 90, 91 , which amplifies the profibrotic effects of the cytokine. However, another subpopulation of M2biased macrophages, referred to as M2a macro phages in some nomenclature schemes, also determines the process of connective tissue production in injured muscles, and they have been identified in increased numbers in regenerative and ageing muscle 11, 35, 37, 42 . M2a macro phages secrete IL10, and express CD206 and arginase 1 (ARG1) 54 . ARG1 has an important role in fibrosis via its metabolism of arginine to yield poly amines, which stimulate fibroblast proliferation, and ornithine, which is metabolized to produce the proline that is required for collagen production 92, 93 . Thus, the net effect of M2biased macrophage function during the later stages of regeneration is to support the production of connective tissue, which is necessary for the complete structural and functional recovery of injured muscle.
What happens when things go wrong?
The efficiency and reliability of muscle regeneration fol lowing acute injury is attributable to natural selection for processes that provide rapid recovery following trauma. By contrast, there is little selective pressure for mech an isms to regenerate muscle that has been subjected to chronic damage because pathologies that give rise to chronic muscle damage are uncommon. Lacking a system adapted to chronic injuries, immune cell modulation of muscle regeneration can go awry, leading to muscle fibro sis and impaired regeneration. These regenerative defects are most thoroughly shown in the mdx mouse model of DMD. DMD and mdx dystrophy involve a mechanically weakened cell membrane, which leads to chronic muscle damage and inflammation 94 . Although numerous patho logical features arise from chronic muscle injury, disrup tions of the normal immune response to muscle damage exacerbate the pathology 95 . Most prominently, chronic injury causes the alteration of macrophages to pheno types for which the normal regulation of connective tissue pro duction is disrupted. At early stages of chronic damage, these macrophages express both M1 and M2 phenotypic markers and, unlike M2biased macrophages from acutely injured wildtype muscle, these transitional macro phages are unable to induce FAP cell apoptosis, leading to increased connective tissue deposition 31 (FIG. 5) . In addi tion, M2biased macrophages in advanced stages of mdx dystrophy shift to a highly fibrogenic state in which there is enhanced ARG1 activity that drives pathological fibro sis in dystrophic muscle 96 . Despite their importance in muscular dystrophy, the mechanisms that underlie the phenotypic specialization of macrophages in chronically injured muscle are unknown.
Just as there are few selective pressures associated with chronic damage, few selective pressures are associ ated with regenerating old muscle in organisms that are beyond reproductive age. Lacking natural selection for maintaining normal muscle interactions with the immune system in old muscle, those interactions become dysregu lated and contribute to defects in muscle regeneration. Ageing and senescent mammals show a progressive loss of the ability of muscle to regenerate following injury 97 , and this is partially attributable to defects in immune cell interactions with ageing muscle. For example, agerelated perturbations in signalling between FAP cells and T reg cells may contribute to slower regeneration of injured muscle in ageing animals. In contrast to young mice in which T reg cell numbers increase within the first 2 days following injury, no T reg cell increase occurs in old injured muscle 98 . This defect was attributed to lower levels of IL33 pro duction by FAP cells. IL33, which is expressed by macro phages, dendritic cells and fibroblasts [98] [99] [100] , is a ligand for IL1 receptorlike 1 (IL1RL1; also known as ST2), which is expressed by CD4 + T cells and macrophages. Currently, FAP cells are the only known source of IL33 in muscle, and their low level of IL33 expression in old muscle is associated with reductions in T reg cell recruit ment and proliferation in injured tissue 98 . However, other factors must underlie the agedependent defect in the regeneration of old muscle. Although the defect in IL33 expression occurs in old mice (aged 22 to 24 months; equivalent to ~68 years old in humans), defective IL33 expression also occurs in 6monthold mice 98 (equivalent to ~28 years old in humans) 101 , which do not experience regenerative defects caused by muscle senescence.
Prospects, challenges and future directions Although recent discoveries illuminate interactions between the immune system and muscle that affect regeneration, have they brought us closer to developing therapies for improving muscle regeneration in humans? The close coupling between the stages of inflammation and the stages of muscle regeneration provides a 'spring board' for preclinical approaches that explore whether manipulating leukocyte populations can promote muscle growth and regeneration. For example, many deficiencies . In addition, in mdx mouse skeletal muscle, which experiences chronic inflammation, there are persistently higher numbers of eosinophils that can cause further damage of muscle fibres through the release of major basic protein (MBP) 131 . Chronic muscle damage also increases the occurrence of a transitional macrophage population that can lead to pathological increases in the number of fibro-adipogenic progenitor (FAP) cells and their profibrotic activities because transforming growth factor-β (TGFβ) production by transitional macrophages counters the negative regulation of their numbers by tumour necrosis factor (TNF) released by M1 macrophages. In addition, chronic muscle inflammation leads to an M2-biased macrophage phenotype in which the levels of expression and activity of arginase are highly elevated, leading to high levels of polyamines that can further expand fibroblast populations and the production of proline, which can increase connective tissue production. IL-10, interleukin-10. Nature Reviews | Immunology 
Muscle damage
Muscle fibres in the functional recovery of muscle that are caused by ischaemia when a tourniquet is applied to a limb can be prevented by injection of BMDMs directly into the injured muscle 102 . However, these functional and struc tural improvements only occurred if the BMDMs were activated with IFNγ and TLR4 ligand before injection, and not when muscles were injected with non activated BMDMs. This could reflect a proregenerative effect that is specifically associated with the M1biased phenotype. Interestingly, the beneficial effects of delivering BMDMs were achieved when the cells were injected 24 hours after tourniquet removal 102 , which suggests that the treatment may have value for improving muscle healing after tour niquet applications following acute trauma on battlefields or roads.
Transplantation of macrophages into muscle can also improve muscle regeneration and function in chronic disease. In an attempt to improve the engraftment of wildtype MPCs in diseased muscle, dystrophic mdx mice were coinjected with PAX7 + MPCs and F4/80 + macrophages; this led to better engraftment and disper sal of transplanted MPCs than did injection of MPCs alone 103 . Macrophages in the treated tissue 5 days post injection were primarily CD206 + , which indicates their polarization towards the M2 phenotype in vivo. In the context of stem cellbased therapeutics for muscular dystrophies, this is a particularly thoughtprovoking outcome because it suggests that suppression of type 2 innate immunity could reduce the engraftment and dispersal of transplanted stem cells.
Our growing knowledge about the influence of the immune system on muscle regeneration has been used in a particularly creative way for developing implanta ble materials to repair volumetric muscle loss (VML), in which there is a traumatic loss of muscle caused by sur gery, blast injuries, car accidents or other severe trauma. Much work in this area focuses on the design and pro duction of synthetic or natural scaffolding materials that are implanted to provide a structure on which regen eration proceeds. Predictably, the immune response to implanted material from natural sources is a major deter minant of whether the scaffold is compatible and sup ports regeneration, or undergoes a foreignbody reaction. However, less predictably, biological scaffolds used for repair of VML that were processed so that their implan tation promoted an innate type 2 immune response yielded more successful regeneration than did scaffolds that produced a proinflammatory response 104, 105 . In fact, skeletal muscle scaffolds that were successfully used for the repair of VML increased the numbers of CD163 + cells and ARG1 + cells, increased IL10 expression and reduced IFNγ expression in the implanted scaffold 106 . Although the mechanisms through which some implant able materials drive a type 2 immune response associated with better engraftment are unknown, highthroughput screening for selecting mat erials for surgical implanta tion now includes in the selection criteria assaying the ability of the test material to influence polarization to the M2biased phenotype 107 . Despite the encouraging findings obtained from manipulating inflammatory cell numbers or pheno type in regenerative muscle in the few examples high lighted in this Review, they reveal the large gap between what we have learned about specific, molecular mech anisms that coordinate muscle regeneration with the immune response and what we have applied to improve regeneration in preclinical and clinical interventions. Learning more about the specific regulatory mechan isms through which the immune system promotes or hinders muscle regeneration can help us to bridge that gap. However, even with that more refined knowledge, achieving appropriate spatial and temporal targeting of therapeutic substances to injured muscle will certainly be a major challenge to developing effective treatments. This point was emphasized by the finding that ablation of CD11b + cells from muscle at day 1 post injury caused substantial defects in muscle regeneration, although their ablation at day 4 did not affect regeneration 26 . Similarly, although endogenous IL10 expressed in injured or diseased muscle promotes regeneration 42, 53 , the delivery of supraphysiological levels of IL10 to injured muscle at earlier stages of repair slows regener ation 108 . This tells us that the time window for immune cellbased interventions to improve muscle repair may be small. Not only will missing the target window lead to ineffective treatment effects, poor timing could also be detrimental. Nevertheless, the field of muscle immuno biology is very young, and the coming years will bring unexpected insights into regulatory processes that may be manipulated to improve recovery from muscle injury or disease. The burgeoning inter actions between devel opmental biologists, immunologists, physiologists, sys tems biologists, clinicians and material scientists whose work focuses on the immunobiology of muscle regener ation will facilitate the translation of these new findings into clinically useful tools.
